Finasteride: A 5 Alpha-Reductase Inhibitor

January 1993 in “ PubMed ”

James F. Steiner

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on pubmed.ncbi.nlm.nih.gov →

Discuss this study in the Community →

Related Research

5 / 5 results

research Dihydrotestosterone And The Role Of 5α-Reductase Inhibitors In Benign Prostatic Hyperplasia

24 citations , September 2002 in “Der Urologe”

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

research A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia

12 citations , January 1998 in “Drug safety”

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

research Evaluation of Men on Finasteride

3 citations , August 1996 in “PubMed”

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

research 5-Alpha-Reductase Inhibitors/Finasteride

4 citations , January 1996 in “PubMed”

research Effect of Finasteride, a 5 Alpha-Reductase Inhibitor, on Serum Gonadotropins in Normal Men

30 citations , August 1992 in “The Journal of Clinical Endocrinology and Metabolism”

Finasteride doesn't affect hormone levels in normal men.